Roche’s Vabysmo improved vision in underrepresented populations with DME in a first-of-its-kind study
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Subscribe To Our Newsletter & Stay Updated